Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.25.3
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Private Placement [Member]
Common Stock [Member]
A T M Offering [Member]
Common Stock [Member]
AOCI Attributable to Parent [Member]
Private Placement [Member]
AOCI Attributable to Parent [Member]
A T M Offering [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Private Placement [Member]
Retained Earnings [Member]
A T M Offering [Member]
Retained Earnings [Member]
Private Placement [Member]
A T M Offering [Member]
Total
Balances (in shares) at Dec. 31, 2023     37,958,000                  
Balances at Dec. 31, 2023     $ 166,609     $ 6     $ (115,558)     $ 51,057
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     5,916                  
Issuance of common shares upon the vesting and settlement of restricted stock units     $ 0     0     0     0
Share-based compensation expense     488     0     0     488
Unrealized gain (loss) on marketable securities     0     (45)     0     (45)
Net loss     $ 0     0     (5,151)     (5,151)
Balance (in shares) at Mar. 31, 2024     37,963,916                  
Balance at Mar. 31, 2024     $ 167,097     (39)     (120,709)     46,349
Balances (in shares) at Dec. 31, 2023     37,958,000                  
Balances at Dec. 31, 2023     $ 166,609     6     (115,558)     $ 51,057
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)                       17,747
Issuance of common shares upon the exercise of stock options (in shares)                       70,750
Unrealized gain (loss) on marketable securities                       $ 75
Net loss                       (16,544)
Balance (in shares) at Sep. 30, 2024     42,766,497                  
Balance at Sep. 30, 2024     $ 179,985     81     (132,102)     47,964
Balances (in shares) at Mar. 31, 2024     37,963,916                  
Balances at Mar. 31, 2024     $ 167,097     (39)     (120,709)     46,349
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     5,916                  
Issuance of common shares upon the vesting and settlement of restricted stock units     $ 0     0     0     0
Issuance of common shares upon the exercise of stock options (in shares)     2,750                  
Issuance of common shares upon the exercise of stock options     $ 7     0     0     7
Share-based compensation expense     443     0     0     443
Unrealized gain (loss) on marketable securities     0     (12)     0     (12)
Net loss     $ 0     0     (5,119)     (5,119)
Issuance of common shares (in shares) 4,720,000                      
Issuance of common shares $ 11,747     $ 0     $ 0     $ 11,747    
Balance (in shares) at Jun. 30, 2024     42,692,582                  
Balance at Jun. 30, 2024     $ 179,294     (51)     (125,828)     53,415
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     5,915                  
Issuance of common shares upon the vesting and settlement of restricted stock units     $ 0     0     0     0
Issuance of common shares upon the exercise of stock options (in shares)     68,000                  
Issuance of common shares upon the exercise of stock options     $ 126     0     0     126
Share-based compensation expense     565     0     0     565
Unrealized gain (loss) on marketable securities     0     132     0     132
Net loss     $ 0     0     (6,274)     (6,274)
Balance (in shares) at Sep. 30, 2024     42,766,497                  
Balance at Sep. 30, 2024     $ 179,985     81     (132,102)     47,964
Balances (in shares) at Dec. 31, 2024     42,818,660                  
Balances at Dec. 31, 2024     $ 180,697     23     (140,002)     40,718
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     3,805                  
Issuance of common shares upon the vesting and settlement of restricted stock units     $ 0     0     0     0
Issuance of common shares upon the exercise of stock options (in shares)     37,000                  
Issuance of common shares upon the exercise of stock options     $ 94     0     0     94
Share-based compensation expense     867     0     0     867
Unrealized gain (loss) on marketable securities     0     (18)     0     (18)
Net loss     $ 0     0     (7,707)     (7,707)
Balance (in shares) at Mar. 31, 2025     42,859,465                  
Balance at Mar. 31, 2025     $ 181,658     5     (147,709)     33,954
Balances (in shares) at Dec. 31, 2024     42,818,660                  
Balances at Dec. 31, 2024     $ 180,697     23     (140,002)     $ 40,718
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)                       11,412
Issuance of common shares upon the exercise of stock options (in shares)                       275,125
Unrealized gain (loss) on marketable securities                       $ 27
Net loss                       $ (24,026)
Issuance of common shares in settlement of deferred stock units (in shares)                       142,345
Issuance of common shares (in shares)                     223,472  
Balance (in shares) at Sep. 30, 2025     52,077,439                  
Balance at Sep. 30, 2025     $ 215,600     50     (164,028)     $ 51,622
Balances (in shares) at Mar. 31, 2025     42,859,465                  
Balances at Mar. 31, 2025     $ 181,658     5     (147,709)     33,954
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     3,803                  
Issuance of common shares upon the vesting and settlement of restricted stock units     $ 0     0     0     0
Issuance of common shares upon the exercise of stock options (in shares)     66,875                  
Issuance of common shares upon the exercise of stock options     $ 163     0     0     163
Share-based compensation expense     771     0     0     771
Unrealized gain (loss) on marketable securities     0     (19)     0     (19)
Net loss     $ 0     0     (7,699)     (7,699)
Issuance of common shares in settlement of deferred stock units (in shares)     142,345                  
Balance (in shares) at Jun. 30, 2025     43,072,488                  
Balance at Jun. 30, 2025     $ 182,592     (14)     (155,408)     27,170
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     3,804                  
Issuance of common shares upon the vesting and settlement of restricted stock units     $ 0     0     0     0
Issuance of common shares upon the exercise of stock options (in shares)     171,250                  
Issuance of common shares upon the exercise of stock options     $ 465     0     0     465
Share-based compensation expense     1,016     0     0     1,016
Unrealized gain (loss) on marketable securities           64           64
Net loss     $ 0     0     (8,620)     (8,620)
Issuance of common shares (in shares) 8,606,425 223,472                    
Issuance of common shares $ 29,977 $ 1,550   $ 0 $ 0   $ 0 $ 0   $ 29,977 $ 1,550  
Balance (in shares) at Sep. 30, 2025     52,077,439                  
Balance at Sep. 30, 2025     $ 215,600     $ 50     $ (164,028)     $ 51,622